Stock KTTA PASITHEA THERAPEUTICS CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Pasithea Therapeutics Corp.

Equities

KTTA

US70261F2020

Delayed Nasdaq
Other stock markets
 11:25:01 16/05/2024 pm IST 		5-day change 1st Jan Change
6.5 USD -2.26% Intraday chart for Pasithea Therapeutics Corp. -15.36% -12.16%
24/04 Pasithea Therapeutics Corp. Announces the First Cohort Has Completed the Initial Dosing in Its Phase 1 Trial Evaluating Pas-004 in Ras, Nf1 and Raf Mutated Cancers CI
29/03 Pasithea Therapeutics Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Pasithea Therapeutics Corp. Appoints Daniel Schneiderman as Chief Financial Officer
CI
Pasithea Therapeutics Corp. Appoints Alfred J. Novak to Its Board of Directors
CI
Pasithea Therapeutics Corp. Appoints Dr. Merit Cudkowicz to its Scientific Advisory Board
CI
Insider Buy: Pasithea Therapeutics
MT
Concord IP2 Ltd Nominates Candidates to the Board of Pasithea Therapeutics Corp
CI
Pasithea Therapeutics Appoints Daniel Weinberger to Its Scientific Advisory Board
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KTTA Stock
  4. News Pasithea Therapeutics Corp.
  5. Insiders
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW